Hedge Fund - Bronte Capital
Regeneron Pharmaceuticals Inc. (REGN)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $114,790,325 | 9.33% | 154,693 | $687.82 |
| 2 | 2024 - Q4 (2024-12-31) | $127,838,251 | 10.24% | 152,783 | $839.22 |
| 3 | 2024 - Q3 (2024-09-30) | $144,064,032 | 12.66% | 137,042 | $1112.86 |
| 4 | 2024 - Q2 (2024-06-30) | $146,570,338 | 11.59% | 139,454 | $969.40 |
| 5 | 2024 - Q1 (2024-03-31) | $139,631,312 | 11.52% | 145,073 | $950.88 |
| 6 | 2023 - Q4 (2023-12-31) | $127,721,810 | 11.69% | 145,421 | $823.50 |
| 7 | 2023 - Q3 (2023-09-30) | $116,401,108 | 12% | 141,442 | $785.91 |
| 8 | 2023 - Q2 (2023-06-30) | $99,385,579 | 9.58% | 138,316 | $771.00 |
| 9 | 2023 - Q1 (2023-03-31) | $112,053,603 | 13% | 136,373 | $754.21 |
| 10 | 2022 - Q4 (2022-12-31) | $102,973 | 12.99% | 142,723 | $737.86 |
| 11 | 2022 - Q3 (2022-09-30) | $101,384,000 | 12.62% | 147,175 | $629.39 |
| 12 | 2022 - Q2 (2022-06-30) | $88,190,000 | 10.1% | 149,189 | $650.01 |
| 13 | 2022 - Q1 (2022-03-31) | $97,092,000 | 8.15% | 139,017 | $632.65 |
| 14 | 2021 - Q4 (2021-12-31) | $82,388,000 | 5.43% | 130,460 | $614.83 |
| 15 | 2021 - Q3 (2021-09-30) | $75,178,000 | 5.5% | 124,224 | $620.82 |
| 16 | 2021 - Q2 (2021-06-30) | $65,611,000 | 4.67% | 117,469 | $506.62 |
| 17 | 2021 - Q1 (2021-03-31) | $28,098,000 | 3.18% | 59,387 | $486.87 |
| 18 | 2020 - Q4 (2020-12-31) | $9,205,000 | 1.45% | 19,053 | $539.80 |
The displayed share prices are average quarterly stock market prices.